These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10359727)

  • 1. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease.
    Kugiyama K; Doi H; Takazoe K; Kawano H; Soejima H; Mizuno Y; Tsunoda R; Sakamoto T; Nakano T; Nakajima K; Ogawa H; Sugiyama S; Yoshimura M; Yasue H
    Circulation; 1999 Jun; 99(22):2858-60. PubMed ID: 10359727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of remnant-like lipoprotein particles in postmenopausal women with and without coronary artery disease and in men with coronary artery disease.
    Fukushima H; Kugiyama K; Sugiyama S; Honda O; Koide S; Nakamura S; Kawano H; Soejima H; Miyamoto S; Yoshimura M; Sakamoto T; Ogawa H
    Am J Cardiol; 2001 Dec; 88(12):1370-3. PubMed ID: 11741554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus.
    Fukushima H; Sugiyama S; Honda O; Koide S; Nakamura S; Sakamoto T; Yoshimura M; Ogawa H; Fujioka D; Kugiyama K
    J Am Coll Cardiol; 2004 Jun; 43(12):2219-24. PubMed ID: 15193683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remnant Lipoproteins Are Residual Risk Factor for Future Cardiovascular Events in Patients With Stable Coronary Artery Disease and On-Statin Low-Density Lipoprotein Cholesterol Levels <70 mg/dL.
    Fujihara Y; Nakamura T; Horikoshi T; Obata JE; Fujioka D; Watanabe Y; Watanabe K; Kugiyama K
    Circ J; 2019 May; 83(6):1302-1308. PubMed ID: 30996151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remnant lipoproteinemia predicts cardiovascular events in patients with type 2 diabetes and chronic kidney disease.
    Nguyen SV; Nakamura T; Uematsu M; Fujioka D; Watanabe K; Watanabe Y; Obata JE; Nakamura K; Kugiyama K
    J Cardiol; 2017 Mar; 69(3):529-535. PubMed ID: 27256217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry.
    Steg PG; Greenlaw N; Tendera M; Tardif JC; Ferrari R; Al-Zaibag M; Dorian P; Hu D; Shalnova S; Sokn FJ; Ford I; Fox KM;
    JAMA Intern Med; 2014 Oct; 174(10):1651-9. PubMed ID: 25110899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High remnant lipoprotein predicts recurrent cardiovascular events on statin treatment after acute coronary syndrome.
    Nguyen SV; Nakamura T; Kugiyama K
    Circ J; 2014; 78(10):2492-500. PubMed ID: 25168189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries.
    Kugiyama K; Doi H; Motoyama T; Soejima H; Misumi K; Kawano H; Nakagawa O; Yoshimura M; Ogawa H; Matsumura T; Sugiyama S; Nakano T; Nakajima K; Yasue H
    Circulation; 1998 Jun; 97(25):2519-26. PubMed ID: 9657472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI).
    Bittner V; Hardison R; Kelsey SF; Weiner BH; Jacobs AK; Sopko G;
    Circulation; 2002 Nov; 106(20):2537-42. PubMed ID: 12427648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remnant Lipoprotein Cholesterol and Mortality After Acute Myocardial Infarction: Further Evidence for a Hypercholesterolemia Paradox From the TRIUMPH Registry.
    Martin SS; Faridi KF; Joshi PH; Blaha MJ; Kulkarni KR; Khokhar AA; Maddox TM; Havranek EP; Toth PP; Tang F; Spertus JA; Jones SR
    Clin Cardiol; 2015 Nov; 38(11):660-7. PubMed ID: 26459191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating oxidized low-density lipoprotein is an independent predictor for cardiac event in patients with coronary artery disease.
    Shimada K; Mokuno H; Matsunaga E; Miyazaki T; Sumiyoshi K; Miyauchi K; Daida H
    Atherosclerosis; 2004 Jun; 174(2):343-7. PubMed ID: 15136065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Prognostic Value of Non-Fasting Lipoproteins and Apolipoproteins in Chinese Patients with Coronary Heart Disease.
    Zhang J; Tang Z; Jiang J; Huang S; Zeng H; Gu J; Wang C; Zhang H
    Rev Cardiovasc Med; 2023 Nov; 24(11):314. PubMed ID: 39076452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies.
    Joshi PH; Khokhar AA; Massaro JM; Lirette ST; Griswold ME; Martin SS; Blaha MJ; Kulkarni KR; Correa A; D'Agostino RB; Jones SR; Toth PP;
    J Am Heart Assoc; 2016 Apr; 5(5):. PubMed ID: 27130348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease.
    Arca M; Montali A; Valiante S; Campagna F; Pigna G; Paoletti V; Antonini R; Barillà F; Tanzilli G; Vestri A; Gaudio C
    Am J Cardiol; 2007 Nov; 100(10):1511-6. PubMed ID: 17996510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
    Thompson SG; Kienast J; Pyke SD; Haverkate F; van de Loo JC
    N Engl J Med; 1995 Mar; 332(10):635-41. PubMed ID: 7845427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased remnant lipoprotein in patients with coronary artery disease--evaluation utilizing a newly developed remnant assay, remnant lipoproteins cholesterol homogenous assay (RemL-C).
    Nakada Y; Kurosawa H; Tohyama J; Inoue Y; Ikewaki K
    J Atheroscler Thromb; 2007 Apr; 14(2):56-64. PubMed ID: 17485889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term prognostic value of lipid measurements in patients with angina pectoris. The ECAT Angina Pectoris Study Group: European Concerted Action on Thrombosis and Disabilities.
    Bolibar I; von Eckardstein A; Assmann G; Thompson S;
    Thromb Haemost; 2000 Dec; 84(6):955-60. PubMed ID: 11154140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.